Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4H647
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 329 | 331 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 384 | 386 | PF00675 | 0.597 |
CLV_NRD_NRD_1 | 420 | 422 | PF00675 | 0.732 |
CLV_NRD_NRD_1 | 63 | 65 | PF00675 | 0.432 |
CLV_PCSK_KEX2_1 | 270 | 272 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 420 | 422 | PF00082 | 0.745 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.432 |
CLV_PCSK_PC1ET2_1 | 270 | 272 | PF00082 | 0.552 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.619 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.314 |
CLV_Separin_Metazoa | 102 | 106 | PF03568 | 0.356 |
DEG_SCF_FBW7_1 | 28 | 35 | PF00400 | 0.746 |
DOC_CYCLIN_RxL_1 | 39 | 49 | PF00134 | 0.441 |
DOC_MAPK_DCC_7 | 225 | 234 | PF00069 | 0.437 |
DOC_MAPK_gen_1 | 201 | 210 | PF00069 | 0.387 |
DOC_MAPK_gen_1 | 39 | 47 | PF00069 | 0.588 |
DOC_MAPK_MEF2A_6 | 33 | 40 | PF00069 | 0.442 |
DOC_PP2B_LxvP_1 | 137 | 140 | PF13499 | 0.364 |
DOC_PP2B_LxvP_1 | 45 | 48 | PF13499 | 0.434 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.535 |
DOC_USP7_MATH_1 | 374 | 378 | PF00917 | 0.511 |
DOC_USP7_UBL2_3 | 270 | 274 | PF12436 | 0.568 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.470 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.654 |
DOC_WW_Pin1_4 | 389 | 394 | PF00397 | 0.656 |
DOC_WW_Pin1_4 | 426 | 431 | PF00397 | 0.506 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.466 |
LIG_14-3-3_CanoR_1 | 105 | 113 | PF00244 | 0.418 |
LIG_14-3-3_CanoR_1 | 204 | 208 | PF00244 | 0.325 |
LIG_14-3-3_CanoR_1 | 33 | 37 | PF00244 | 0.686 |
LIG_14-3-3_CanoR_1 | 362 | 367 | PF00244 | 0.507 |
LIG_14-3-3_CanoR_1 | 95 | 101 | PF00244 | 0.488 |
LIG_Actin_WH2_2 | 90 | 107 | PF00022 | 0.397 |
LIG_BRCT_BRCA1_1 | 376 | 380 | PF00533 | 0.578 |
LIG_EH_1 | 319 | 323 | PF12763 | 0.400 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.299 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.547 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.444 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.350 |
LIG_FHA_1 | 209 | 215 | PF00498 | 0.596 |
LIG_FHA_1 | 222 | 228 | PF00498 | 0.515 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.417 |
LIG_FHA_1 | 64 | 70 | PF00498 | 0.501 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.550 |
LIG_LIR_Apic_2 | 325 | 329 | PF02991 | 0.382 |
LIG_LIR_Gen_1 | 62 | 73 | PF02991 | 0.399 |
LIG_LIR_Gen_1 | 99 | 109 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 99 | 104 | PF02991 | 0.327 |
LIG_Pex14_2 | 322 | 326 | PF04695 | 0.384 |
LIG_PTB_Apo_2 | 125 | 132 | PF02174 | 0.456 |
LIG_PTB_Apo_2 | 64 | 71 | PF02174 | 0.387 |
LIG_PTB_Phospho_1 | 64 | 70 | PF10480 | 0.409 |
LIG_SH2_CRK | 135 | 139 | PF00017 | 0.342 |
LIG_SH2_CRK | 299 | 303 | PF00017 | 0.346 |
LIG_SH2_CRK | 408 | 412 | PF00017 | 0.534 |
LIG_SH2_CRK | 414 | 418 | PF00017 | 0.612 |
LIG_SH2_CRK | 65 | 69 | PF00017 | 0.367 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.333 |
LIG_SH2_GRB2like | 355 | 358 | PF00017 | 0.505 |
LIG_SH2_GRB2like | 65 | 68 | PF00017 | 0.383 |
LIG_SH2_SRC | 355 | 358 | PF00017 | 0.561 |
LIG_SH2_SRC | 408 | 411 | PF00017 | 0.520 |
LIG_SH2_SRC | 414 | 417 | PF00017 | 0.453 |
LIG_SH2_STAP1 | 122 | 126 | PF00017 | 0.348 |
LIG_SH2_STAP1 | 135 | 139 | PF00017 | 0.388 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 297 | 300 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 65 | 68 | PF00017 | 0.423 |
LIG_SH3_1 | 270 | 276 | PF00018 | 0.454 |
LIG_SH3_3 | 233 | 239 | PF00018 | 0.438 |
LIG_SH3_3 | 270 | 276 | PF00018 | 0.430 |
LIG_SH3_3 | 404 | 410 | PF00018 | 0.665 |
LIG_SH3_4 | 405 | 412 | PF00018 | 0.691 |
LIG_TRAF2_1 | 84 | 87 | PF00917 | 0.511 |
LIG_TRFH_1 | 70 | 74 | PF08558 | 0.511 |
LIG_UBA3_1 | 137 | 143 | PF00899 | 0.501 |
LIG_WRC_WIRS_1 | 97 | 102 | PF05994 | 0.308 |
MOD_CDK_SPK_2 | 28 | 33 | PF00069 | 0.445 |
MOD_CK1_1 | 206 | 212 | PF00069 | 0.375 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.688 |
MOD_CK2_1 | 253 | 259 | PF00069 | 0.554 |
MOD_CK2_1 | 81 | 87 | PF00069 | 0.540 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.475 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.538 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.360 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.543 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.522 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.410 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.453 |
MOD_GSK3_1 | 235 | 242 | PF00069 | 0.567 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.717 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.502 |
MOD_GSK3_1 | 335 | 342 | PF00069 | 0.497 |
MOD_GSK3_1 | 420 | 427 | PF00069 | 0.673 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.618 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.529 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.697 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.377 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.376 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.414 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.686 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.563 |
MOD_NEK2_1 | 332 | 337 | PF00069 | 0.360 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.539 |
MOD_PIKK_1 | 104 | 110 | PF00454 | 0.366 |
MOD_PIKK_1 | 72 | 78 | PF00454 | 0.546 |
MOD_PKA_1 | 420 | 426 | PF00069 | 0.734 |
MOD_PKA_1 | 63 | 69 | PF00069 | 0.442 |
MOD_PKA_2 | 104 | 110 | PF00069 | 0.397 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.715 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.508 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.322 |
MOD_PKA_2 | 32 | 38 | PF00069 | 0.664 |
MOD_PKA_2 | 346 | 352 | PF00069 | 0.526 |
MOD_PKA_2 | 361 | 367 | PF00069 | 0.537 |
MOD_PKA_2 | 420 | 426 | PF00069 | 0.742 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.535 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.482 |
MOD_Plk_4 | 420 | 426 | PF00069 | 0.741 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.483 |
MOD_Plk_4 | 96 | 102 | PF00069 | 0.428 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.463 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.652 |
MOD_ProDKin_1 | 389 | 395 | PF00069 | 0.649 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.466 |
MOD_SUMO_for_1 | 280 | 283 | PF00179 | 0.455 |
MOD_SUMO_rev_2 | 111 | 118 | PF00179 | 0.466 |
TRG_DiLeu_BaLyEn_6 | 40 | 45 | PF01217 | 0.447 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.351 |
TRG_ENDOCYTIC_2 | 408 | 411 | PF00928 | 0.603 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.392 |
TRG_ER_diArg_1 | 2 | 5 | PF00400 | 0.679 |
TRG_ER_diArg_1 | 63 | 65 | PF00400 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 225 | 230 | PF00026 | 0.512 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5Y0 | Leptomonas seymouri | 73% | 100% |
A0A0N1PDA3 | Leptomonas seymouri | 32% | 100% |
A0A0S4INL4 | Bodo saltans | 48% | 100% |
A0A0S4JAJ5 | Bodo saltans | 31% | 100% |
A0A1X0NQR5 | Trypanosomatidae | 68% | 100% |
A0A1X0P2H5 | Trypanosomatidae | 31% | 100% |
A0A3Q8IH71 | Leishmania donovani | 89% | 100% |
A0A3R7M1X1 | Trypanosoma rangeli | 65% | 100% |
A0A3R7MCA7 | Trypanosoma rangeli | 31% | 100% |
A0A3S7X6N8 | Leishmania donovani | 33% | 100% |
A4HLI1 | Leishmania braziliensis | 31% | 100% |
A4HUG7 | Leishmania infantum | 89% | 100% |
A4I8Z1 | Leishmania infantum | 33% | 100% |
C9ZVI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 86% |
D0A4Y9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9AN65 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
E9B3W0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
Q4Q464 | Leishmania major | 32% | 100% |
Q4QHG0 | Leishmania major | 89% | 100% |
V5B205 | Trypanosoma cruzi | 67% | 100% |
V5BLV5 | Trypanosoma cruzi | 30% | 100% |